{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T01:56:07Z","timestamp":1782266167571,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T00:00:00Z","timestamp":1470700800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s10067-016-3368-9","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T12:39:41Z","timestamp":1470746381000},"page":"2619-2623","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association between rheumatoid arthritis and systemic mastocytosis: a case report and literature review"],"prefix":"10.1007","volume":"35","author":[{"given":"Ichraq","family":"Latar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meriem","family":"Koufany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Hablot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Loeuille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Netter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Jouzeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Chary-Valckenaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,9]]},"reference":[{"key":"3368_CR1","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, et al. (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 69:1580\u20131588. doi: 10.1136\/ard.2010.138461","journal-title":"Ann Rheum Dis"},{"key":"3368_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1056\/NEJMra1409760","volume":"373","author":"TC Theoharides","year":"2015","unstructured":"Theoharides TC, Valent P, Akin C (2015) Mast cells, mastocytosis, and related disorders. N Engl J Med 373:163\u2013172. doi: 10.1056\/NEJMra1409760","journal-title":"N Engl J Med"},{"key":"3368_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.iac.2014.01.002","volume":"34","author":"G Cruse","year":"2014","unstructured":"Cruse G, Metcalfe DD, Olivera A (2014) Functional deregulation of KIT: link to mast cell proliferative diseases and other neoplasms. Immunol Allergy Clin N Am 34:219\u2013237. doi: 10.1016\/j.iac.2014.01.002","journal-title":"Immunol Allergy Clin N Am"},{"key":"3368_CR4","first-page":"65","volume":"8","author":"D Magliacane","year":"2014","unstructured":"Magliacane D, Parente R, Triggiani M (2014) Current concepts on diagnosis and treatment of mastocytosis. Transl Med UniSa 8:65\u201374","journal-title":"Transl Med UniSa"},{"key":"3368_CR5","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(96)07056-0","volume":"349","author":"L Golkar","year":"1997","unstructured":"Golkar L, Bernhard JD (1997) Mastocytosis. Lancet 349:1379\u20131385. doi: 10.1016\/S0140-6736(96)07056-0","journal-title":"Lancet"},{"key":"3368_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-4939-1568-2_7","volume":"1220","author":"EJ DeBruin","year":"2015","unstructured":"DeBruin EJ, Gold M, Lo BC, et al. (2015) Mast cells in human health and disease. Methods Mol Biol 1220:93\u2013119. doi: 10.1007\/978-1-4939-1568-2_7","journal-title":"Methods Mol Biol"},{"key":"3368_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/mi.2009.136","volume":"3","author":"TC Moon","year":"2010","unstructured":"Moon TC, St Laurent CD, Morris KE, et al. (2010) Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal Immunol 3:111\u2013128. doi: 10.1038\/mi.2009.136","journal-title":"Mucosal Immunol"},{"key":"3368_CR8","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.jaci.2006.04.017","volume":"117","author":"MF Gurish","year":"2006","unstructured":"Gurish MF, Boyce JA (2006) Mast cells: ontogeny, homing, and recruitment of a unique innate effector cell. J Allergy Clin Immunol 117:1285\u20131291. doi: 10.1016\/j.jaci.2006.04.017","journal-title":"J Allergy Clin Immunol"},{"key":"3368_CR9","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/ni.f.216","volume":"9","author":"J Kalesnikoff","year":"2008","unstructured":"Kalesnikoff J, Galli SJ (2008) New developments in mast cell biology. Nat Immunol 9:1215\u20131223. doi: 10.1038\/ni.f.216","journal-title":"Nat Immunol"},{"key":"3368_CR10","doi-asserted-by":"publisher","first-page":"e1002619","DOI":"10.1371\/journal.ppat.1002619","volume":"8","author":"M Urb","year":"2012","unstructured":"Urb M, Sheppard DC (2012) The role of mast cells in the defence against pathogens. PLoS Pathog 8:e1002619. doi: 10.1371\/journal.ppat.1002619","journal-title":"PLoS Pathog"},{"key":"3368_CR11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nri2782","volume":"10","author":"SN Abraham","year":"2010","unstructured":"Abraham SN, St John AL (2010) Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol 10:440\u2013452. doi: 10.1038\/nri2782","journal-title":"Nat Rev Immunol"},{"key":"3368_CR12","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nm.2755","volume":"18","author":"SJ Galli","year":"2012","unstructured":"Galli SJ, Tsai M (2012) IgE and mast cells in allergic disease. Nat Med 18:693\u2013704. doi: 10.1038\/nm.2755","journal-title":"Nat Med"},{"key":"3368_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2015.04.046","author":"G Cruse","year":"2015","unstructured":"Cruse G, Bradding P (2015) Mast cells in airway diseases and interstitial lung disease. Eur J Pharmacol. doi: 10.1016\/j.ejphar.2015.04.046","journal-title":"Eur J Pharmacol"},{"key":"3368_CR14","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1136\/ard.2009.124511","volume":"69","author":"S Barete","year":"2010","unstructured":"Barete S, Assous N, de Gennes C, et al. (2010) Systemic mastocytosis and bone involvement in a cohort of 75 patients. Ann Rheum Dis 69:1838\u20131841. doi: 10.1136\/ard.2009.124511","journal-title":"Ann Rheum Dis"},{"key":"3368_CR15","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.2353\/ajpath.2009.080871","volume":"174","author":"M Biosse-Duplan","year":"2009","unstructured":"Biosse-Duplan M, Baroukh B, Dy M, et al. (2009) Histamine promotes osteoclastogenesis through the differential expression of histamine receptors on osteoclasts and osteoblasts. Am J Pathol 174:1426\u20131434. doi: 10.2353\/ajpath.2009.080871","journal-title":"Am J Pathol"},{"key":"3368_CR16","doi-asserted-by":"publisher","first-page":"1127.e1","DOI":"10.1016\/j.amjmed.2014.06.015","volume":"127","author":"M Rossini","year":"2014","unstructured":"Rossini M, Zanotti R, Viapiana O, et al. (2014) Zoledronic acid in osteoporosis secondary to mastocytosis. Am J Med 127:1127.e1\u20131127.e4. doi: 10.1016\/j.amjmed.2014.06.015","journal-title":"Am J Med"},{"key":"3368_CR17","doi-asserted-by":"publisher","first-page":"75.e1","DOI":"10.1016\/j.amjmed.2012.07.018","volume":"126","author":"N Guillaume","year":"2013","unstructured":"Guillaume N, Desoutter J, Chandesris O, et al. (2013) Bone complications of mastocytosis: a link between clinical and biological characteristics. Am J Med 126:75.e1\u201375.e7. doi: 10.1016\/j.amjmed.2012.07.018","journal-title":"Am J Med"},{"key":"3368_CR18","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.amjmed.2011.02.038","volume":"124","author":"M Laroche","year":"2011","unstructured":"Laroche M, Livideanu C, Paul C, Cantagrel A (2011) Interferon alpha and pamidronate in osteoporosis with fracture secondary to mastocytosis. Am J Med 124:776\u2013778. doi: 10.1016\/j.amjmed.2011.02.038","journal-title":"Am J Med"},{"key":"3368_CR19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/rheumatology\/36.3.393","volume":"36","author":"A Marshall","year":"1997","unstructured":"Marshall A, Kavanagh RT, Crisp AJ (1997) The effect of pamidronate on lumbar spine bone density and pain in osteoporosis secondary to systemic mastocytosis. Br J Rheumatol 36:393\u2013396","journal-title":"Br J Rheumatol"},{"key":"3368_CR20","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1359\/jbmr.2002.17.4.567","volume":"17","author":"C Brumsen","year":"2002","unstructured":"Brumsen C, Hamdy NAT, Papapoulos SE (2002) Osteoporosis and bone marrow mastocytosis: dissociation of skeletal responses and mast cell activity during long-term bisphosphonate therapy. J Bone Miner Res 17:567\u2013569. doi: 10.1359\/jbmr.2002.17.4.567","journal-title":"J Bone Miner Res"},{"key":"3368_CR21","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1136\/ard.2004.029116","volume":"64","author":"AYN Lim","year":"2005","unstructured":"Lim AYN, Ostor AJK, Love S, Crisp AJ (2005) Systemic mastocytosis: a rare cause of osteoporosis and its response to bisphosphonate treatment. Ann Rheum Dis 64:965\u2013966. doi: 10.1136\/ard.2004.029116","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 6","key":"3368_CR22","doi-asserted-by":"publisher","first-page":"vi5","DOI":"10.1093\/rheumatology\/kes279","volume":"51","author":"J Kay","year":"2012","unstructured":"Kay J, Upchurch KS (2012) ACR\/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology 51(Suppl 6):vi5\u2013vi9. doi: 10.1093\/rheumatology\/kes279","journal-title":"Rheumatology"},{"key":"3368_CR23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/art.1780400314","volume":"40","author":"I Gotis-Graham","year":"1997","unstructured":"Gotis-Graham I, McNeil HP (1997) Mast cell responses in rheumatoid synovium. Association of the MCTC subset with matrix turnover and clinical progression. Arthritis Rheum 40:479\u2013489","journal-title":"Arthritis Rheum"},{"key":"3368_CR24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/PL00012386","volume":"49","author":"HP McNeil","year":"2000","unstructured":"McNeil HP, Gotis-Graham I (2000) Human mast cell subsets--distinct functions in inflammation? Inflamm Res 49:3\u20137","journal-title":"Inflamm Res"},{"key":"3368_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/ard.60.3.187","volume":"60","author":"N Olsson","year":"2001","unstructured":"Olsson N, Ulfgren AK, Nilsson G (2001) Demonstration of mast cell chemotactic activity in synovial fluid from rheumatoid patients. Ann Rheum Dis 60:187\u2013193. doi: 10.1136\/ard.60.3.187","journal-title":"Ann Rheum Dis"},{"key":"3368_CR26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1042\/cs0930363","volume":"93","author":"MG Buckley","year":"1997","unstructured":"Buckley MG, Walters C, Wong WM, et al. (1997) Mast cell activation in arthritis: detection of alpha- and beta-tryptase, histamine and eosinophil cationic protein in synovial fluid. Clin Sci 93:363\u2013370","journal-title":"Clin Sci"},{"key":"3368_CR27","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.4049\/jimmunol.0903566","volume":"184","author":"AJ Hueber","year":"2010","unstructured":"Hueber AJ, Asquith DL, Miller AM, et al. (2010) Mast cells express IL-17\u00a0A in rheumatoid arthritis synovium. J Immunol 184:3336\u20133340. doi: 10.4049\/jimmunol.0903566","journal-title":"J Immunol"},{"key":"3368_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/art.33396","volume":"64","author":"T Noordenbos","year":"2012","unstructured":"Noordenbos T, Yeremenko N, Gofita I, et al. (2012) Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis. Arthritis Rheum 64:99\u2013109. doi: 10.1002\/art.33396","journal-title":"Arthritis Rheum"},{"key":"3368_CR29","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cyto.2007.09.013","volume":"40","author":"D Moulin","year":"2007","unstructured":"Moulin D, Donz\u00e9 O, Talabot-Ayer D, et al. (2007) Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 40:216\u2013225. doi: 10.1016\/j.cyto.2007.09.013","journal-title":"Cytokine"},{"key":"3368_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205562","author":"J Suurmond","year":"2014","unstructured":"Suurmond J, Rivellese F, Dorj\u00e9e AL, et al. (2014) Toll-like receptor triggering augments activation of human mast cells by anti-citrullinated protein antibodies. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2014-205562","journal-title":"Ann Rheum Dis"},{"key":"3368_CR31","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/eji.201243058","volume":"43","author":"J Suurmond","year":"2013","unstructured":"Suurmond J, van Heemst J, van Heiningen J, et al. (2013) Communication between human mast cells and CD4(+) T cells through antigen-dependent interactions. Eur J Immunol 43:1758\u20131768. doi: 10.1002\/eji.201243058","journal-title":"Eur J Immunol"},{"key":"3368_CR32","doi-asserted-by":"publisher","first-page":"6467","DOI":"10.1073\/pnas.0501912102","volume":"102","author":"S Nakae","year":"2005","unstructured":"Nakae S, Suto H, Kakurai M, et al. (2005) Mast cells enhance T cell activation: importance of mast cell-derived TNF. Proc Natl Acad Sci U S A 102:6467\u20136472. doi: 10.1073\/pnas.0501912102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3368_CR33","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.4049\/jimmunol.167.7.4008","volume":"167","author":"D Baram","year":"2001","unstructured":"Baram D, Vaday GG, Salamon P, et al. (2001) Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha. J Immunol 167:4008\u20134016","journal-title":"J Immunol"},{"key":"3368_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2015.03.085","author":"J Suurmond","year":"2015","unstructured":"Suurmond J, van der Velden D, Kuiper J, et al. (2015) Mast cells in rheumatic disease. Eur J Pharmacol. doi: 10.1016\/j.ejphar.2015.03.085","journal-title":"Eur J Pharmacol"},{"key":"3368_CR35","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.4049\/jimmunol.1300856","volume":"191","author":"NJ Magarinos","year":"2013","unstructured":"Magarinos NJ, Bryant KJ, Fosang AJ, et al. (2013) Mast cell-restricted, tetramer-forming tryptases induce aggrecanolysis in articular cartilage by activating matrix metalloproteinase-3 and \u221213 zymogens. J Immunol 191:1404\u20131412. doi: 10.4049\/jimmunol.1300856","journal-title":"J Immunol"},{"key":"3368_CR36","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1007\/s00198-013-2305-x","volume":"24","author":"S Seitz","year":"2013","unstructured":"Seitz S, Barvencik F, Koehne T, et al. (2013) Increased osteoblast and osteoclast indices in individuals with systemic mastocytosis. Osteoporos Int 24:2325\u20132334. doi: 10.1007\/s00198-013-2305-x","journal-title":"Osteoporos Int"},{"key":"3368_CR37","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.semarthrit.2014.05.016","volume":"44","author":"B Bader-Meunier","year":"2014","unstructured":"Bader-Meunier B, Livideanu CB, Larroche C, et al. (2014) Association of mastocytosis with inflammatory joint diseases_ a series of 31 patients. Semin Arthritis Rheum 44:362\u2013365. doi: 10.1016\/j.semarthrit.2014.05.016","journal-title":"Semin Arthritis Rheum"},{"key":"3368_CR38","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1600-065X.2007.00504.x","volume":"217","author":"KK Eklund","year":"2007","unstructured":"Eklund KK (2007) Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapy. Immunol Rev 217:38\u201352. doi: 10.1111\/j.1600-065X.2007.00504.x","journal-title":"Immunol Rev"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3368-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-016-3368-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3368-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T20:16:07Z","timestamp":1498335367000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-016-3368-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,9]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["3368"],"URL":"https:\/\/doi.org\/10.1007\/s10067-016-3368-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,9]]}}}